23 results
8-K/A
EX-3.1
THER
Theralink Technologies, Inc.
11 Jul 22
Amendments to Articles of Incorporation or Bylaws
7:29pm
8-K
EX-3.1
THER
Theralink Technologies, Inc.
7 Jul 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
10-K
2021 FY
EX-3.1
THER
Theralink Technologies, Inc.
Annual report
13 Jan 22
12:00am
8-K
EX-3.1
THER
Theralink Technologies, Inc.
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
10-Q
2020 Q3
EX-3.1
THER
Theralink Technologies, Inc.
Quarterly report
11 Jun 21
12:00am
8-K
EX-3.1
cwc4ta70o5qh6zgv
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.2
swu9teuc4ef6dvnyb
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.3
as3njqvd0
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.5
p5koyte8
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.4
tkim 4sl2h0
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.1
ewx9cglw 3u
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.1
eqkehqlgyoeklijd83f
13 Sep 19
Material Modifications to Rights of Security Holders
5:16pm
8-K
EX-3.1
my3y12
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
EX-3.1
pewyuz4xe272m tf
1 Nov 13
QUINT Engages Lexicon for Entertainment Public Relations
12:00am
8-K
EX-3.1
08gnadxzn3k1mtyxdctl
8 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.2
b2zdtv70 b0
8 Aug 13
Departure of Directors or Certain Officers
12:00am